Inhibition of nifedipine metabolism in dogs by erythromycin: Difference between the gut wall and the liver

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 12, 1997, Pages 1205-1210

  Tsuruta, Satoshi ^a   Nakamura, Kazumi ^a   Arimori, Kazuhiko ^a   Nakano, Masahiro ^a  

^a KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; NIFEDIPINE; ROKITAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; INTESTINE MUCOSA; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER METABOLISM; LIVER MICROSOME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEAL CAVITY; RAT;

EID: 0031464487     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06071.x     Document Type: Article

References (20)

1. Bailey, D. G., Bend, J. B., Arnold, M. O., Tran, L. T., Spence, J. D. (1996) Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Clin. Pharmacol. Ther. 60: 25-33
2. Gomez, D. Y., Wacher, V. J., Tomlanovich, S. J., Hebert, M. F., Benet, L. Z. (1995) The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. Clin. Pharmacol. Ther. 58: 15-19
3. Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P., Wolff, T., Waxman, D. J. (1986) Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 261: 5051-5060
4. Guengerich, F. P., Brian, W. R., Iwasaki, M., Sari, M. A., Baarnhielm, C., Berntsson, P. (1991) Oxidation of dihydropyridine calcium-channel blockers and analogues by human liver cytochrome P-450 3A4. J. Med. Chem. 34: 1838-1844
5. Kamataki, T., Sugiura, M., Yamazoe, Y., Kato, R. (1979) Purification and properties of cytochrome P-450 and NADPH-cytochrome c (P-450) reductase from human liver microsomes. Biochem. Pharmacol. 28: 1993-2000
6. Klaus, D. R., Johannes, S. (1983) Pharmacokinetics and metabolism of nifedipine. Hypertension 5 (Suppl. II): 18-24
7. Kolars, J. C., Awni, W. N., Merion, R. M., Watkins, P. B. (1991) First-pass metabolism of cyclosporine by the gut. Lancet 338: 1488-1490
8. Krishna, D. R., Klotz, U. (1994) Extrahepatic metabolism of drugs in humans. Clin. Pharmacokinet. 26: 144-160
9. Liedholm, H., Nordin, G. (1991) Erythromycin-felodipine interaction. DICP, Ann. Pharmacother. 25: 1007-1008
10. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
11. Marre, F., Sousa, G., Orloff, A. M., Rahmani, R. (1993) In-vitro interaction between cyclosporin A and macrolide antibiotics. Br. J. Clin. Pharmacol. 35: 447-448
12. Periti, P., Mazzei, T., Mini, E., Novelli, A. (1992) Pharmacokinetic drug interaction of macrolides. Clin. Pharmacokinet. 23: 106-131
13. Rashid, T. J., Martin, U., Clarke, H., Waller, D. G., Renwick, A. G., George, C. F. (1995) Factors affecting the absolute bioavailability of nifedipine. Br. J. Clin. Pharmacol. 40: 51-58
14. Roosemalen, M. C. M., Soons, P. A., Funaki, T., Breimer, D. (1991) High-performance liquid chromatographic determination of the polar metabolites of nifedipine in plasma, blood and urine. J. Chromatogr. 565: 516-522
15. Schlanz, K. D., Myre, S. A., Bottorff, M. B. (1991a) Pharmacokinetic interactions with calcium channel antagonists (Part I). Clin. Pharmacokinet. 21: 344-356
16. Schlanz, K. D., Myre, S. A., Bottorff, M. B. (1991b) Pharmacokinetic interactions with calcium channel antagonists (Part D). Clin. Pharmacokinet. 21: 448-460
17. Tsuruta, S., Matsumura, K., Tsuruta, S., Imanura, K., Arimori, K., Nakano, M. (1995) The mechanism of pharmacokinetic interaction between nifedipine and quinidine. Jpn J. Clin. Pharmacol. Ther. 26: 793-801
18. Tsuruta, S., Nakamura, K., Arimori, K., Nakano, M. (1997) Effects of erythromycin, clarithromycin and rokitamycin on nifedipine metabolism in rats. Biol. Pharm. Bull. 20: 411-416
19. Wang, S. X., Sutfin, T. A., Baarnhielm, C., Regard, C. (1989) Contribution of the intestine to the first-pass metabolism of felodipine in the rat. J. Pharmacol. Exp. Ther. 250: 632-636
20. Yamaoka, N., Nakagawa, T., Uno, T. (1978) Statistical moments in pharmacokinetics. J. Pharmacokin. Biopharm. 6: 547-558